Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation
- PMID: 63657
- DOI: 10.1016/s0140-6736(77)91655-5
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation
Abstract
Fresh rings of arteries and veins obtained from surgical specimens generated an unstable substance, prostacyclin (prostaglandinx, [P.G.X]) WHICH IS A POTENT INHIBITOR OF PLATELET AGGREGATION. The spontaneous generation of prostacyclin as well as its generation from exogenous arachidonic acid was inhibit by incubation of the tissues with a prostaglandin-synthetase inhibitor such as indomethacin, whilst the generation induced by prostaglandin endoperoxides was not. 15-Hydroperoxyarachidonic acid (a lipid hydroperoxide) inhibited the generation of prostacyclin in all three situations. It is postulated that prostacyclin is important for prevention of deposition of platelets on the vessel wall and that the inhibition or prevention of the generation of prostacyclin is important in the genesis of diseases, especially those in which increased lipid peroxidation occurs, such as atherosclerosis.
Similar articles
-
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.Prostaglandins. 1976 Dec;12(6):897-913. doi: 10.1016/0090-6980(76)90125-8. Prostaglandins. 1976. PMID: 1005741
-
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.Prostaglandins. 1976 Nov;12(5):715-37. doi: 10.1016/0090-6980(76)90048-4. Prostaglandins. 1976. PMID: 824686
-
Prostacyclin and arterial wall biology.Arteriosclerosis. 1982 May-Jun;2(3):193-207. doi: 10.1161/01.atv.2.3.193. Arteriosclerosis. 1982. PMID: 6284099 Review. No abstract available.
-
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.Prostaglandins. 1976 Nov;12(5):685-713. doi: 10.1016/0090-6980(76)90047-2. Prostaglandins. 1976. PMID: 824685
-
Prostaglandins, platelets, and atherosclerosis.CRC Crit Rev Biochem. 1980;7(4):291-338. doi: 10.3109/10409238009105464. CRC Crit Rev Biochem. 1980. PMID: 6771102 Review.
Cited by
-
Novel insights into the vasoprotective role of heme oxygenase-1.Int J Hypertens. 2012;2012:127910. doi: 10.1155/2012/127910. Epub 2012 Feb 22. Int J Hypertens. 2012. PMID: 22518279 Free PMC article.
-
In vitro prostacyclin production in the hemolytic-uremic syndrome.West J Med. 1986 Feb;144(2):165-8. West J Med. 1986. PMID: 3754077 Free PMC article.
-
Interaction of antiphospholipid antibodies with endothelial cells in antiphospholipid syndrome.Front Immunol. 2024 Jul 9;15:1361519. doi: 10.3389/fimmu.2024.1361519. eCollection 2024. Front Immunol. 2024. PMID: 39044818 Free PMC article. Review.
-
Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.Proc Natl Acad Sci U S A. 1977 Sep;74(9):3922-6. doi: 10.1073/pnas.74.9.3922. Proc Natl Acad Sci U S A. 1977. PMID: 333448 Free PMC article.
-
The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.Int J Mol Sci. 2022 Jul 27;23(15):8283. doi: 10.3390/ijms23158283. Int J Mol Sci. 2022. PMID: 35955419 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials